Code
FSH-AMLF-03BX
Panel
Active-Compendium
88374x3 automated. Codes may differ if manual analysis is performed.
Clinical
Pathology
Bone marrow aspirate: 1-2 mL sodium heparin tube. EDTA tube is acceptable.
Peripheral blood: 2-5 mL sodium heparin tube. EDTA tube is acceptable.
Fresh, unfixed tissue: Tissue in RPMI.
Bone Marrow/ Peripheral Blood Smear or Fresh Tissue Touch Preparation Slides: minimum 3 slides labeled with specimen type.
Fluids: Equal parts RPMI to specimen volume.
Fixed Cell Suspension: A client fixed cell suspension may be submitted for testing as long as it is received in 3:1 Methanol:Glacial Acetic Acid.
Paraffin block or cut slides: Not available.
Note: Please exclude biopsy needles, blades, and other foreign objects from transport tubes. These can compromise specimen viability and yield, and create hazards for employees.
Peripheral blood: 2-5 mL sodium heparin tube. EDTA tube is acceptable.
Fresh, unfixed tissue: Tissue in RPMI.
Bone Marrow/ Peripheral Blood Smear or Fresh Tissue Touch Preparation Slides: minimum 3 slides labeled with specimen type.
Fluids: Equal parts RPMI to specimen volume.
Fixed Cell Suspension: A client fixed cell suspension may be submitted for testing as long as it is received in 3:1 Methanol:Glacial Acetic Acid.
Paraffin block or cut slides: Not available.
Note: Please exclude biopsy needles, blades, and other foreign objects from transport tubes. These can compromise specimen viability and yield, and create hazards for employees.
Flag Active
True
Orderable Test Description
Probes: RUNX1/RUNX1T1 (ETO/AML1) t(8;21) | PML/RARA t(15;17) | CBFB inv(16), t(16;16)
Disease(s): Acute myeloid leukemia
Probes may be ordered separately.
Disease(s): Acute myeloid leukemia
Probes may be ordered separately.
Orderable Turn Around Time
3-5 Days
Keywords
Extra Note
Use cold pack for transport, making sure cold pack is not in direct contact with specimen. NYS clients please provide date and time of Collection.
Orderable Biomarkers
NY Approved
True
Orderable Biomarkers JSON
{"Fluorescence In Situ Hybridization (FISH)": {"Inversion(s)": ["CBFB inv(16), t(16;16)"], "Translocation(s)": ["PML/RARA t(15;17)", "RUNX1T1/RUNX1 (ETO/AML1) t(8;21)"]}}
Keywords string
favorable-risk, AML, acute myeloid leukemia AML Favorable-Risk Panel
Title URL
aml-favorable-risk-panel